Overview
Dr. Rubin was one of 300 Ophthalmologists in the US selected to study a new steroid which was evaluated for use in asthma and allergy. In 2005 he was the Boucher Lecturer at USC Estelle Doheny Eye Center. Dr. Rubin has lectured at the NIH, the University of Illinois Eye and Ear Hospital and at the Jules Stein Eye Institute at UCLA. He was at the NIH for 15 years and has been involved in the care of patients with many eye disease and those related to receiving treatment for Melanoma, Bone Marrow/Stem Cell Transplant, Sickle Cell Disease, Cystanosis and NOMID. The latter two are very rare diseases, the treatments of which have resulted in remarkable benefit to the patients. Another interest has been in the treatment of severe dry eye. He was the recipient of the prestigious Richard C. Troutman Award in Ophthalmology at SUNY Downstate Medical College in April 2007. Dr. Rubin is a co-author in a number of prestigious journals, including the New England Journal of Medicine. Together with Dr. James Fielding Hejtmanick, he was involved in the discovery of the gene responsible for Francois Neetans Cornea Dystrophy. Dr. Rubin received a patent for a drug that inactivates Matrix Metallo Protease from the United States Patent and Trade Office. His research with this drug is ongoing and this may be a major contribution to the treatment of eye and medical diseases. He continues to collaborate with Dr. Hejmanick looking for the gene responsible for Pterygium, Fuch’s Dystrophy, Familial Macula Degeneration. He continues to collaborate with Manuel Datiles, MD at the National Eye Institute on Hypo-Alpha Protein cataracts, a cataract that affects men and women in their 50-60''s. His research continues to keep him involved in academics and abreast of the most recent discoveries in many fields of medicine.
Dr. Rubin is rated as an Experienced provider by MediFind in the treatment of Optic Nerve Atrophy. His top areas of expertise are Glaucoma, Increased Intracranial Pressure, Optic Atrophy Type 1, and Optic Nerve Atrophy.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- HMO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Potomac, MD 20854
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Farhad Naseh MD PA
Farhad Naseh is an Ophthalmologist in Gaithersburg, Maryland. Dr. Naseh is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. His top areas of expertise are Glaucoma, Optic Atrophy Type 1, Optic Nerve Atrophy, and Hereditary Keratitis. Dr. Naseh is currently accepting new patients.
Jeffrey Sedgewick is an Ophthalmologist in Ashburn, Virginia. Dr. Sedgewick is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Optic Atrophy Type 1, Optic Nerve Atrophy, and Glaucoma.
Martin Kolsky is an Ophthalmologist in Washington, Washington, D.c.. Dr. Kolsky is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. His top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Glaucoma, and Optic Glioma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AlbinismDr. Rubin isExperienced. Learn about Albinism.
- Allergic ConjunctivitisDr. Rubin isExperienced. Learn about Allergic Conjunctivitis.
- Bell's PalsyDr. Rubin isExperienced. Learn about Bell's Palsy.
- BlepharitisDr. Rubin isExperienced. Learn about Blepharitis.
- CataractDr. Rubin isExperienced. Learn about Cataract.
- ChalazionDr. Rubin isExperienced. Learn about Chalazion.